FOSTER CITY, Calif., April 14, 2025--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation ...

When selecting the appropriate formulation of Livmarli, the patient's weight and ability to swallow tablets should be considered. Livmarli tablets are supplied in 10mg, 15mg, 20mg, and 30mg dosage ...

In this interview, the main uses and benefits of NIR spectroscopy in tableting are discussed. Oral-solid dosage (OSD) forms remain a popular choice for both pharmaceutical companies and patients.

13-Week Study to Evaluate the Safety and Efficacy of Oral VK2735 Dosed Once Daily SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage ...

The Food and Drug Administration initially approved the chewable tablet formulation in January 2017. Vyvanse (lisdexamfetamine dimesylate; Shire) is now available as chewable tablets for the treatment ...

An early formulation strategy for tablets that is simple and scalable is recommended to ensure fewer downstream problems. The oral solid dosage formulation market is anticipated to experience growth ...

Roche has announced that a tablet formulation of its spinal muscular atrophy (SMA) treatment Evrysdi (risdiplam) has been approved by the US Food and Drug Administration (FDA). Evrysdi was originally ...

The trial conducted by the British researchers enrolled 30 participants who were previously unvaccinated and 12 participants who had previously received a standard two-dose vaccine course by injection ...

Validating the match between the active ingredient content mentioned in the packaging and the actual content in each tablet in a batch is a critical step in tablet manufacture. Highly precise ...